WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹31 Cr | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-13 Cr |
What is the latest Consolidated Net Profit of WANBURY ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹81 Cr |
| Mar2021 | ₹-13 Cr |
How is Consolidated Net Profit of WANBURY Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | -45.44 | |
| Mar2024 | ₹56 Cr | Positive | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹81 Cr | Positive | |
| Mar2021 | ₹-13 Cr | - | |
Compare Consolidated Net Profit of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹805.1 Cr | -2.6% | -10.6% | 3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -2.6% |
-10.6% |
3% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses